About 9 results found for searched term "90-50-6" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1934 | Tacrolimus (FK506) | Autophagy |
| Fujimycin; FR900506; Prograf | ||
| Tacrolimus (FK506, FR900506, Fujimycin, Prograf) is a potent, clinically-useful immunosuppressant in the same molecular class as cyclosporin A and rapamycin. *The compound is unstable in solutions, freshly prepared is recommended | ||
| M6293 | Tacrolimus monohydrate | Antibiotic |
| Fujimycin monohydrate; FR900506 monohydrate; FK506 monohydrate | ||
| Tacrolimus monohydrate binds to FK506 binding protein (FKBP). This complex inhibits calcineurin phosphatase (PP2B). Tacrolimus monohydrate is a mTOR-independent autophagy inducer. | ||
| M16355 | ent-Labda-8(17),13E-diene-3β,15,18-triol | Diterpenoids |
| ent-Labda-8(17),13E-diene-3β,15,18-triol | ||
| M25278 | Pegdinetanib | VEGFR/PDGFR |
| BMS-844203; CT-322 | ||
| Pegdinetanib (BMS-844203; CT-322) is a selective VEGFR-2 (VEGFR) inhibitor with Kds of 11 nM and 250 nM and IC50s of 16 nM and 240 nM for human and murine VEGFR-2, respectively. Pegdinetanib does not bind to VEGFR-1 or VEGFR-3. Pegdinetanib has antitumor activity. | ||
| M39022 | 3,4,5-Trimethoxycinnamic acid | GABA Receptor |
| 3,4,5-Trimethoxycinnamic acid has anti-stress effect, prolonging the sleeping time in animals. 3,4,5-Trimethoxycinnamic acid increases expression of GAD65 and γ-subunit of GABAA receptor, but shows no effect on the amounts of α-, β-subunits. | ||
| M40859 | Schizophyllan | Adjuvants |
| Schizophyllan, a β-D-glucan derived from Schizophyllan, activates Tc cells, NK cells, macrophages, as well as promotes the secretion of various lymphokines such as IL-1, IL-2, IL-3, IFN. It can be used as an immune adjuvant with potential immunomodulatory and antitumor activities. | ||
| M42836 | TSPP tetrasodium | Fluorescent Dye |
| TSPP tetrasodium is a photosensitizer that has shown impressive effects in in vivo regression of cancer and microorganism infections (Ex: 413 nm, Em: 640 nm). | ||
| M49426 | α-Conotoxin PIA TFA | AChR/AChE |
| α-Conotoxin PIA TFA is a nicotinic acetylcholine receptor (nAChR) antagonist that targets the nAChR, which contains both the α6 and α3 subunits. α-Conotoxin PIA TFA can be used in studies related to Parkinson's disease and schizophrenia. | ||
| M56317 | TG8-260 | Prostaglandin Receptor |
| TG8-260 is a second-generation EP2 antagonist developed to alleviate the pathology of central nervous system and peripheral diseases driven by inflammation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
